Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Deep Learning for Distinguishing Morphological Features of Acute Promyelocytic Leukemia

John-William Sidhom, MSc, Ingharan J Siddarthan, Bo-Shiun Lai, PhD, Adam Luo, Bryan Hambley, MD, Jennifer Bynum, MD, Amy S. Duffield, MD PhD, Michael B. Streiff, MD, Alison R. Moliterno, MD, Philip H. Imus, MD, Christian B. Gocke, MD PhD, Lukasz P. Gondek, MDPhD, Amy E. DeZern, MD, Alexander S Baras, MDPhD, Thomas S. Kickler, MD, Mark Levis, MD PhD, Eugene Shenderov, MDDPhil

Blood (2020) 136 (Supplement 1): 10–12.

https://doi.org/10.1182/blood-2020-135836

Published: 2020

Journal Articles

Risk Factors for Pregnancy-Associated Venous Thromboembolism: The Role of Maternal Age, Obesity, Smoking and Other Modifiable Risk Factors

Rahil Kohli, Alison R. Moliterno, MD, Michael B. Streiff, MD, Michael R. DeBaun, MD, Thomas S. Kickler, MD, Karin Blakemore, Shruti Chaturvedi, MBBS, MS

Blood (2018) 132 (Supplement 1): 3804.

https://doi.org/10.1182/blood-2018-99-113599

Published: 2018

Journal Articles

Parallel Evaluation of Three Global Hemostatic Assays in Response to Factor VIII Inhibitors

Ping Chen, PhD, Jayesh Jani, Gang Zheng, MD PhD, Thomas S. Kickler, MD

Blood (2018) 132 (Supplement 1): 1172.

https://doi.org/10.1182/blood-2018-99-110722

Published: 2018

Journal Articles

Modified Ham Test Distinguishes aHUS from TTP and Predicts Response to Eculizumab

Eleni Gavriilaki, MD, Xuan Yuan, MD MSc, Zhaohui Ye, PhD, Michael B. Streiff, MD, Thomas S Kickler, MD, Alison R Moliterno, MD, John Sperati, MD, Robert A. Brodsky, MD

Blood (2015) 126 (23): 103.

https://doi.org/10.1182/blood.V126.23.103.103

Published: 2015

Journal Articles

Does the Platelet Factor 4 (PF4) ELISA Correlate with the Clinical Diagnosis of Type II Heparin-Induced Thrombocytopenia?.

Michael B. Streiff, MD, Thomas S. Kickler, MD, Edward G. Weir, MD

Blood (2005) 106 (11): 2179.

https://doi.org/10.1182/blood.V106.11.2179.2179

Published: 2005

Journal Articles

Heparin-Induced Thrombocytopenia Antibodies Do Not Predict Adverse Outcomes in End-Stage Renal Disease Patients on Dialysis.

Lars M. Asmis, MD, Jodi B. Segal, MD, MPH, Laura C. Plantinga, MPH, Nancy E. Fink, MPH, Jonathan S. Kerman, Thomas S. Kickler, MD, Josef Coresh, MD, Lawrence B. Gardner, MD

Blood (2004) 104 (11): 3517.

https://doi.org/10.1182/blood.V104.11.3517.3517

Published: 2004

NARROW

Deep Learning for Distinguishing Morphological Features of Acute Promyelocytic Leukemia

Risk Factors for Pregnancy-Associated Venous Thromboembolism: The Role of Maternal Age, Obesity, Smoking and Other Modifiable Risk Factors

Parallel Evaluation of Three Global Hemostatic Assays in Response to Factor VIII Inhibitors

Modified Ham Test Distinguishes aHUS from TTP and Predicts Response to Eculizumab

Does the Platelet Factor 4 (PF4) ELISA Correlate with the Clinical Diagnosis of Type II Heparin-Induced Thrombocytopenia?.

Heparin-Induced Thrombocytopenia Antibodies Do Not Predict Adverse Outcomes in End-Stage Renal Disease Patients on Dialysis.

Email alerts

ASH Publications

American Society of Hematology

Deep Learning for Distinguishing Morphological Features of Acute Promyelocytic Leukemia

Risk Factors for Pregnancy-Associated Venous Thromboembolism: The Role of Maternal Age, Obesity, Smoking and Other Modifiable Risk Factors

Parallel Evaluation of Three Global Hemostatic Assays in Response to Factor VIII Inhibitors

Modified Ham Test Distinguishes aHUS from TTP and Predicts Response to Eculizumab

Does the Platelet Factor 4 (PF4) ELISA Correlate with the Clinical Diagnosis of Type II Heparin-Induced Thrombocytopenia?.

Heparin-Induced Thrombocytopenia Antibodies Do Not Predict Adverse Outcomes in End-Stage Renal Disease Patients on Dialysis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only